Latest Breaking News On - Omar boraie - Page 1 : comparemela.com

Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care

Shridar Ganesan, MD, PhD, discusses the current limitations and advantages of leveraging circulating-tumor DNA to detect minimal residual disease in patients with cancer, as well as how ctDNA assays may address mechanisms of resistance in clinical practice.

Omar boraieShridar ganesanRwjbarnabas healthRutgers cancer institute of new jerseyMolecular oncologyTranslational scienceOmar boraie chairGenomic scienceRutgers cancer instituteNew jerseyCancer care

2023 Commercial Real Estate Power 50: A – H

2023 Commercial Real Estate Power 50: A – H
njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.

United statesDirector parkNew yorkNew jerseyEast rutherfordWoodland parkNorth carolinaBernard schoolSummit eastBergen countyUniversity of miamiColumbia universityMonmouth countyWest orangeJersey cityAtlantic city

After 16 Years, Bayonne Peninsula Project Lurches Forward

After 16 Years, Bayonne Peninsula Project Lurches Forward
therealdeal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from therealdeal.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNew jerseyJersey cityHudson countyWasseem boraieOmar boraieTrammell crowRobert mazzuocolaJames davisSharon ashe nadrowskiMark smithKate howardBoraie omarKushner real estate groupRedevelopment authority

Intestinal microbiome may contribute to the pathogenesis of MSI colon cancers, study suggests

Investigators from Rutgers Cancer Institute of New Jersey, New Jersey's only National Cancer Institute- Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including microsatellite-stable and unstable (MSI) tumors.

New jerseyUnited statesShridar ganesanOmar boraieRussell madisonEmily hendersonFoundation medicineRutgers robert wood johnson medical schoolGenomic science at rutgers cancer instituteNational cancer designated comprehensive centerRutgers cancer institute of new jerseyRutgers cancer instituteNational cancerComprehensive cancer centerOmar boraie chairGenomic science

George Mason, Rutgers partner to better inform HER2 breast cancer treatment

E-Mail IMAGE: Lance Liotta, MD, PhD, study PI, and George Mason University College of Science CAPMM co-founder and co-director. view more Credit: Evan Cantwell, George Mason University A George Mason University and Rutgers Cancer Institute of New Jersey collaboration received the U.S. Army s Breast Cancer Research Program (BCRP) Breakthrough Award to quickly confirm if an identified HER2 biomarker can indicate success likelihood of personalized breast cancer treatments. George Mason University s College of Science announced an exciting $1.33 million collaboration with Rutgers Cancer Institute of New Jersey and Mason s Center for Applied Proteomics and Molecular Medicine (CAPMM) which taps cancer research diagnostics and treatment strengths within the medical facilities and CAP/CLIA laboratory respectively of the two regional powerhouses.

United statesShridar ganesanFernando miralles wilhelmEmanuel petricoinOmar boraieLance liottaRutgers robert wood johnson medical schoolGeorge mason universityMason centerGeorge mason university is virginiaRutgers cancer institute of new jerseyMason college of scienceUs army breast cancer research programGeorge mason university college of scienceVa george mason universityRwjbarnabas health